Pradžia › Vėžys (visų tipų) › Ohio › Columbus
Vėžys (visų tipų) klinikiniai tyrimai Columbus, OH
38 tyrimai dėl Vėžys (visų tipų) ieško dalyvių vietose Columbus ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.
Oficialus tyrimo tekstas (anglų kalba)
Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →
A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
Renkami dalyviai1/2 fazė
- GSK Investigational Site, Columbus
Met Non Small Cell Cancer Registry (MOMENT)
Renkami dalyviaiStebimasis tyrimas
- The Ohio State University Wexner Medical Center, Columbus
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Renkami dalyviaiStebimasis tyrimas
- Ohio State University, Columbus
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Renkami dalyviai3 fazė
- The Ohio State University, Columbus
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Renkami dalyviaiStebimasis tyrimas
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
Renkami dalyviai2 fazė
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0008), Columbus
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Renkami dalyviai3 fazė
- Quetzal Site 8, Columbus
Pan Tumor Rollover Study
Renkami dalyviai2 fazė
- The Ohio University, Columbus
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Renkami dalyviai2/3 fazė
- Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Collection of Tissue Samples for Cancer Research
Renkami dalyviaiStebimasis tyrimas
- Ohio State University, Columbus
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Renkami dalyviai2 fazė
- The Ohio State University, Department of Psychiatry, Columbus
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Renkami dalyviai3 fazė
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Renkami dalyviaiStebimasis tyrimas
- Ohio State University, Columbus
Project: Every Child for Younger Patients With Cancer
Renkami dalyviaiStebimasis tyrimas
- Nationwide Children's Hospital, Columbus
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Renkami dalyviai1/2 fazė
- The Ohio State University Comprehensive Cancer Center, Columbus
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Renkami dalyviai2 fazė
- Nationwide Children's Hosp, Columbus
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Renkami dalyviai3 fazė
- Ohio State University Comprehensive Cancer Center, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- Riverside Methodist Hospital, Columbus
- ir dar 8
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
Renkami dalyviai2 fazė
- Nationwide Children's Hospital, Columbus
The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients
Renkami dalyviai
- Nationwide Children's Hospital, Columbus
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Renkami dalyviai1/2 fazė
- The Ohio State University /ID# 271336, Columbus
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Renkami dalyviai1 fazė
- The Ohio State University Comprehensive Cancer Center, Columbus
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Renkami dalyviai1/2 fazė
- Stefanie Spielman Comprehensive Breast Center, Columbus
Childhood Cancer Survivor Study
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
- Nationwide Children's Hospital, Columbus
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
Renkami dalyviaiStebimasis tyrimas
- Ohio State University, Columbus
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Renkami dalyviai1/2 fazė
- The Ohio State University Comprehensive Cancer Center, Columbus
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
Renkami dalyviai2 fazė
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Renkami dalyviai1/2 fazė
- The Ohio State University Wexner Medical Center, Columbus
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Renkami dalyviai1/2 fazė
- Ohio State University Wexner Medical Center Gynecologic Oncology at Mill Run, Columbus
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Renkami dalyviai2 fazė
- The Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus
Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
Renkami dalyviaiStebimasis tyrimas
- Ohio State University Wexner Medical Center, Columbus
Re-Engaging AYA Survivors in Cancer-Related Healthcare
Renkami dalyviai
- Nationwide Children's Hospital, Columbus
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Renkami dalyviai2 fazė
- The Ohio State University /ID# 230439, Columbus
GEMINI-NSCLC: NSCLC Biomarker Study
Renkami dalyviaiStebimasis tyrimas
- Ohio State University, Columbus
- OhioHealth Reseach Institute, Columbus
Preparing for Life and Academics for Young Childhood Cancer Survivors
Renkami dalyviai
- Nationwide Children's Hospital, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Renkami dalyviaiStebimasis tyrimas
- Massive Bio SYNERGY-AI site, Columbus
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Renkami dalyviai1/2 fazė
- The Ohio State University, Columbus
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Renkami dalyviaiStebimasis tyrimas
- Ohio State University, Columbus
- OhioHealth Research Institute, Columbus
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Renkami dalyviai
- Ohio State University Comprehensive Cancer Center, Columbus
Vėžys (visų tipų) tyrimai kituose miestuose
- Houston, TX121 tyrimas
- New York City, NY110 tyrimai
- Boston, MA86 tyrimai
- Los Angeles, CA73 tyrimai
- Nashville, TN65 tyrimai
- Philadelphia, PA59 tyrimai
- Durham, NC58 tyrimai
- Washington, DC58 tyrimai
- Chicago, IL51 tyrimas
- Seattle, WA49 tyrimai
- Atlanta, GA49 tyrimai
- Arlington, VA48 tyrimai
Kiti tyrimai Columbus
- Nedidelinių ląstelių plaučių vėžys56 tyrimai
- Krūties vėžys39 tyrimai
- Kiaušidžių vėžys39 tyrimai
- Plaučių vėžys37 tyrimai
- Ūmi mieloidinė leukemija35 tyrimai
- Lėtinė limfocitinė leukemija28 tyrimai
- Metastatinis vėžys27 tyrimai
- Endometrio vėžys25 tyrimai
- Storosios ir tiesiosios žarnos vėžys24 tyrimai
- Prostatos vėžys24 tyrimai
- Kartotinė mieloma24 tyrimai
- Melanoma21 tyrimas
Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.